Capital expenditure · 2011–2025
Pacific Biosciences of California capital expenditure
$2.7M−56.1% · FY2025
Pacific Biosciences of California (PACB) reported $2.7M in capital expenditure for fiscal 2025, −56.1% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.7M | −56.1% | Open → |
| FY20242024-12-31 | $6.2M | −30.0% | Open → |
| FY20232023-12-31 | $8.8M | −47.2% | Open → |
| FY20222022-12-31 | $16.8M | +182.4% | Open → |
| FY20212021-12-31 | $5.9M | +470.8% | Open → |
| FY20202020-12-31 | $1.0M | −63.4% | Open → |
| FY20192019-12-31 | $2.8M | +53.0% | Open → |
| FY20182018-12-31 | $1.9M | −82.2% | Open → |
| FY20172017-12-31 | $10.4M | +27.1% | Open → |
| FY20162016-12-31 | $8.2M | +172.7% | Open → |
| FY20152015-12-31 | $3.0M | +87.0% | Open → |
| FY20142014-12-31 | $1.6M | +77.0% | Open → |
| FY20132013-12-31 | $909,000 | −46.6% | Open → |
| FY20122012-12-31 | $1.7M | −81.7% | Open → |
| FY20112011-12-31 | $9.3M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −8.4%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pacific Biosciences of California capital expenditure |url=https://companiesranked.com/en/company/pacific-biosciences-of-california/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pacific Biosciences of California capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/pacific-biosciences-of-california/capital-expenditureBibTeX
@misc{companiesranked-en-company-pacific-biosciences-of-california-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Pacific Biosciences of California capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pacific-biosciences-of-california/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001299130-26-000034 · February 25, 2026
{{cite web |title=Pacific Biosciences of California capital expenditure — 10-K (0001299130-26-000034) |url=https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/pacb-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.